Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OTTx Peptide Candidate (Short Bowel)
- Development stage
- Preclinical
- Lead developer
- On Target Therapeutics
- Modality
- Peptides
01
Overview
OTTx Peptide Candidate (Short Bowel) is a preclinical-stage therapeutic being developed by On Target Therapeutics for the treatment of short bowel syndrome (SBS). The drug is designed as a stable, long-acting peptide modulator of an unspecified G protein-coupled receptor (GPCR). The company's platform focuses on engineering peptide modulators with enhanced stability and extended duration of action compared to endogenous ligands, with the goal of improving therapeutic outcomes in gastrointestinal disorders. As of current reports, the program is in the preclinical phase, with the developer seeking industry partners for co-development to advance the candidate into Phase I or Phase II clinical trials.
- Other names
- OTTx-On Target Therapeutics-GPCR (unspecified)-peptide-short bowel syndromeOTTx Peptide Candidate (Short Bowel Syndrome)
Beyond the preview
Go deeper on OTTx Peptide Candidate (Short Bowel).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OTTx Peptide Candidate (Short Bowel).